awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33920750-4CEA58D7-C3BE-4470-8367-825F09197941
Q33920750-4CEA58D7-C3BE-4470-8367-825F09197941
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33920750-4CEA58D7-C3BE-4470-8367-825F09197941
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).
P2860
Q33920750-4CEA58D7-C3BE-4470-8367-825F09197941
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33920750-4CEA58D7-C3BE-4470-8367-825F09197941
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8cdc19da2b393095c6db1ebae117f4608e51030f
P2860
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.